SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Martinón-Torres, F; García-Sastre, A; Pollard, AJ; Martín, C; Osterhaus, A; Ladhani, SN; Ramilo, O; Gómez Rial, J; Salas, A; Bosch, FX; et al. Martinón-Torres, F; García-Sastre, A; Pollard, AJ; Martín, C; Osterhaus, A; Ladhani, SN; Ramilo, O; Gómez Rial, J; Salas, A; Bosch, FX; Martinón-Torres, M; Mina, MJ; Cherry, J (2021) TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO). Hum Vaccin Immunother, 17 (11). pp. 4299-4327. ISSN 2164-554X https://doi.org/10.1080/21645515.2021.1953351
SGUL Authors: Ladhani, Shamez Nizarali

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (609kB) | Preview

Abstract

TIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts.

Item Type: Article
Additional Information: © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Keywords: COVID-19 pandemic, Infectious disease, control of transmission, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), vaccine-immunity response, vaccine-preventable disease, COVID-19, Communicable Diseases, Humans, Influenza Vaccines, Pandemics, SARS-CoV-2, Humans, Communicable Diseases, Influenza Vaccines, Pandemics, COVID-19, SARS-CoV-2, Infectious disease, vaccine-preventable disease, COVID-19 pandemic, control of transmission, vaccine-immunity response, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 1107 Immunology, 1108 Medical Microbiology, 1115 Pharmacology and Pharmaceutical Sciences, Virology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Hum Vaccin Immunother
ISSN: 2164-554X
Language: eng
Dates:
DateEvent
2 November 2021Published
11 November 2021Published Online
2 July 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDInstituto de Salud Carlos IIIhttp://dx.doi.org/10.13039/501100004587
PI070069Fondo de Investigación SanitariaUNSPECIFIED
PI1601569Fondo de Investigación SanitariaUNSPECIFIED
UNSPECIFIEDfondos FEDERUNSPECIFIED
Proyectos GaIN Rescata-Covid_IN845D 2020/23GAINUNSPECIFIED
PI1000540Fondo de Investigación SanitariaUNSPECIFIED
PI1901090Fondo de Investigación SanitariaUNSPECIFIED
PubMed ID: 34762551
Web of Science ID: WOS:000717355800001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114696
Publisher's version: https://doi.org/10.1080/21645515.2021.1953351

Actions (login required)

Edit Item Edit Item